Visalytics
Visalytics
remanded EB-2 (NIW) RFE Issued

Doctoral Research Fellow

Biomedical Sciences And Microbiology · 2024-10-10

Decision Date
2024-10-10
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to investigate the roles that environmental and genetic factors play in the development of Type 1 Diabetes. This involves conducting a comprehensive study analyzing diverse populations with Type 1 Diabetes and healthy controls to pinpoint specific environmental exposures and genetic variations, using advanced genomic techniques to identify genetic risk variants and their interaction with environmental triggers. The ultimate goal is to uncover new insights into the mechanisms underlying Type 1 Diabetes pathogenesis to pave the way for personalized preventive strategies and more targeted treatments.

Framework Evaluation

1 of 3 criteria met
1 The proposed endeavor has both substantial merit and national importance Met

The AAO found the petitioner's research on Type 1 Diabetes, utilizing emerging biotechnologies, has substantial merit and national importance due to its alignment with national priorities and potential for broad impact.

2 The individual is well-positioned to advance their proposed endeavor Not Met

The AAO found the Director's conclusion that this prong was met lacked adequate explanation and remanded for further consideration. The AAO noted the evidence did not appear to demonstrate the work renders her well-positioned.

3 On balance, waiving the job offer requirement would benefit the United States Not Met

The AAO found the Director's conclusion that this prong was not met lacked proper evaluation of evidence and specific claims, remanding for further consideration. The AAO reiterated that economic impact is not strictly required.

Why This Petition Was Remanded

The AAO withdrew the Director's decision and remanded the case. While the AAO found Prong 1 (substantial merit and national importance) was met due to the research's alignment with national priorities and potential impact on diabetes treatment, it found the Director failed to adequately explain the basis for finding Prong 2 (well-positioned) met and did not properly evaluate Prong 3 (national benefit of waiver). The AAO noted the petitioner had three citations over four papers, but the sole diabetes-related paper had no citations, and no evidence of being a recipient of scientific research grants.

Request for Evidence (RFE)

Unsuccessfully Addressed

The Director's decision mentioned evidence received in an RFE, but the specific requests of the RFE and how the petitioner responded are not detailed in the provided text. The AAO noted the Director *may* issue an RFE on remand.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Grants
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Biotechnology

USCIS EB-2 (NIW) dismissed
2025-01-22
The petitioner proposes to continue research on the structure, function, and interaction of proteins as a foundation for developing novel therapeutic targets and innovative approaches for disease intervention. This research specifically targets diseases such as Alzheimer's and other neurodegenerative conditions.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 63 days 2025-02-26
The petitioner proposes to continue research in structural biology, specifically elucidating the structure of critical human cell membrane proteins. This work aims to uncover molecular mechanisms driving cancer and neurological diseases to facilitate the development of novel therapeutic pathways and improved drug treatment options.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Connecticut 428 days 2021-05-19
The petitioner proposes to continue his research in biology and biomedical informatics, specifically focusing on the expansion of biomedical ontologies and the study of regulated exocytosis. His work aims to address the health and economic burdens of neurodegenerative, immune, and inherited diseases, including the development of new avenues for diabetes drug design.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
New Jersey 6 days 2024-10-10
The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.
View Case

Frequently Asked Questions

A remanded EB-2 NIW petition means the case was sent back to the field office for further review. This happens when procedural errors are found or additional evidence should be considered. It is neither an approval nor a denial.

Browse More Cases

More remanded cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-10.

Browse all cases

At a Glance

Outcome remanded
RFE Issued
Criteria Met 1 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist